Tegafur/gimeracil/oteracil-induced eosinophilic pneumonia

Toshiyuki Sumi; Hisashi Nakata; Yuji Mori; Hiroki Takahashi

doi:10.1002/rcr2.551

Tegafur/gimeracil/oteracil-induced eosinophilic pneumonia

Respirol Case Rep. 2020 Mar 10;8(4):e00551. doi: 10.1002/rcr2.551. eCollection 2020 May.

Authors

Toshiyuki Sumi^{1

2}, Hisashi Nakata¹, Yuji Mori¹, Hiroki Takahashi²

Affiliations

¹ Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan.
² Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan.

Abstract

Clinicians should be aware that eosinophilic pneumonia is one of the types of drug-induced lung injury that can be caused by tegafur/gimeracil/oteracil (TS-1).

Keywords: Drug‐induced pneumonia; TS‐1; eosinophilic pneumonia.